North America Blood Glucose Monitoring Market Size (2024 - 2029)

The North America Blood Glucose Monitoring Market is projected to experience significant growth over the forecast period, driven by an increasing diabetic population and the rising prevalence of diabetes-related conditions. The market's expansion is influenced by factors such as the high incidence of Type-2 diabetes, particularly among individuals recovering from COVID-19, and the growing use of blood monitoring devices like continuous glucose monitors. North America's dominance in the insulin therapeutics sector, coupled with lifestyle changes and heightened awareness of diabetes care, further contributes to the market's anticipated growth.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Monitoring Devices Research Single time Monitoring Devices Research North America Blood Glucose Monitoring Market Market Size

Market Size of North America Blood Glucose Monitoring Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
North America Blood Glucose Monitoring Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 15.51 Billion
Market Size (2029) USD 28.74 Billion
CAGR (2024 - 2029) 13.13 %

Major Players

North America Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

North America Blood Glucose Monitoring Market Analysis

The North America Blood Glucose Monitoring Market size is estimated at USD 15.51 billion in 2024, and is expected to reach USD 28.74 billion by 2029, growing at a CAGR of 13.13% during the forecast period (2024-2029).

In North America, diabetes incidence of Type-2 diabetes and other diabetes forms was numerically higher in individuals with COVID-19. Insulin resistance and impaired insulin secretion have been described in individuals without diabetes history who recovered from SARS-CoV-2 infections. It has been suggested that diagnosis and treatment of post-COVID-19 syndrome require integrated rather than disease-specific approaches.

Over the past decade, there has been a tremendous increase in the diabetic population globally. Several reports and surveys documented a drastic increase in the diabetic population based on the changes in lifestyles and habits. The growing diabetic population drives blood monitoring devices, such as CGM. Nearly 90% of Type-1 diabetic patients in developed countries use a glucometer. Almost 50% of Type-2 patients are expected to use a glucometer during the forecast period.

North America dominates the global insulin therapeutics market due to the high prevalence of diabetes in the region, the sedentary lifestyle, and the launch of new drugs. The United States is expected to grow tremendously during the forecast period, owing to factors such as the high prevalence of obesity and increasing awareness regarding diabetes care in the region.

Therefore, due to the abovementioned factors, the market studied is anticipated to witness growth during the forecast period.

North America Blood Glucose Monitoring Industry Segmentation

Although glucose meters are an excellent tool, it is important to occasionally monitor blood sugar levels more closely. A continuous glucose meter (CGM) gadget is one aid in this situation. Blood sugar levels are monitored day and night by this FDA-approved system. Every 5 to 15 minutes, it automatically takes readings. The North American blood glucose monitoring market is witnessing a market size of USD 10.3 billion in the current year. It is anticipated to register a CAGR of over 7% during the forecast period. 

The North American glucose monitoring market is segmented by type (self-monitoring blood glucose (glucometer devices, test strips, and lancets) and continuous glucose monitoring (sensors and durables)) and geography (United States, Canada, and Rest of North America). The report offers market size and forecasts for all the above segments in value (USD) and volume (in units).

Device
Self-monitoring Blood Glucose Devices
Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring
Sensors
Durables
End User
Hospital/Clinics
Home/Personal
Geography
United States
Canada
Rest of North America
Need A Different Region Or Segment?
Customize Now

North America Blood Glucose Monitoring Market Size Summary

The North America blood glucose monitoring market is poised for significant growth, driven by the increasing prevalence of diabetes and the rising adoption of advanced monitoring technologies. The market is characterized by a growing diabetic population, largely due to lifestyle changes, which in turn fuels the demand for blood glucose monitoring devices such as continuous glucose monitors (CGMs) and glucometers. The region's dominance in the global insulin therapeutics market is attributed to factors like a high prevalence of diabetes, sedentary lifestyles, and the introduction of new drugs. The United States, in particular, is expected to see substantial growth, supported by heightened awareness of diabetes care and the prevalence of obesity. Innovations in diabetes care devices, including those by startups and established companies, are further propelling market expansion.

The market landscape is highly fragmented, with a mix of major players and generic manufacturers. CGM devices, which offer real-time glucose level monitoring and trend analysis, are gaining traction due to technological advancements and cost reductions, such as cell phone integration. Despite the higher expenditure by Type-1 diabetic patients on these devices, the adoption among Type-2 patients is also expected to rise, driven by increased national awareness and the introduction of more affordable options. The market is witnessing steady growth as companies like Abbott and Dexcom receive regulatory approvals for their products, enhancing their market presence. The ongoing innovations and strategic initiatives by key players are anticipated to positively impact the market dynamics in the coming years.

Explore More

North America Blood Glucose Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. Market Segmentation

    1. 2.1 Device

      1. 2.1.1 Self-monitoring Blood Glucose Devices

        1. 2.1.1.1 Glucometer Devices

        2. 2.1.1.2 Test Strips

        3. 2.1.1.3 Lancets

      2. 2.1.2 Continuous Glucose Monitoring

        1. 2.1.2.1 Sensors

        2. 2.1.2.2 Durables

    2. 2.2 End User

      1. 2.2.1 Hospital/Clinics

      2. 2.2.2 Home/Personal

    3. 2.3 Geography

      1. 2.3.1 United States

      2. 2.3.2 Canada

      3. 2.3.3 Rest of North America

North America Blood Glucose Monitoring Market Size FAQs

The North America Blood Glucose Monitoring Market size is expected to reach USD 15.51 billion in 2024 and grow at a CAGR of 13.13% to reach USD 28.74 billion by 2029.

In 2024, the North America Blood Glucose Monitoring Market size is expected to reach USD 15.51 billion.

North America Blood Glucose Monitoring Market Report Snapshots

North America Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)